Home > Insider Trading > Filing (0001181431-11-059448)

Filing Details

Accession Number:: 0001181431-11-059448
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-12-08 13:14:02
Reporting Period:: 2011-11-30

Filing Date:: 2011-12-08
Accepted Time:: 2011-12-08 13:14:02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1361103	Complete Genomics Inc	GNOM	Services-Commercial Physical & Biological Research (8731)	203226545

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1134570	Jr P Charles Waite	C/O Ovp Venture Partner 1010 Market Street Kirkland WA 98033		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001	Acquisiton	2011-11-30	1,666	$0.00	1,666	No	4	M	Direct
Common Stock, Par Value $0.001	Disposition	2011-12-06	42,575	$3.13	2,626,895	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Indirect	See Footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2011-11-30	1,666	$0.00	1,666	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,334			No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, Par Value $0.001	32,079	Indirect	See Footnote

Footnotes

The shares were acquired upon vesting and conversion of Restricted Stock Units, which were received as a grant for which no consideration was paid.
The transaction was executed in multiple trades in prices ranging from $3.10 to $3.16, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
The shares are owned by OVP Venture Partners VI, L.P. ("OVP VI"). OVMC VI, LLC ("OVMC VI LLC") serves as the general partner of OVP VI. Charles P. Waite, Jr. is a managing member of OVMC VI LLC and shares voting and investment power over the shares held by OVP VI. The Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of his proportionate pecuniary interest therein.
The shares are owned by OVP VI Entrepreneurs Fund, L.P. (OVP VI Entrepreneurs"). OVMC VI LLC serves as the general partner of OVP VI Entrepreneurs. Charles P. Waite, Jr. is a managing member of OVMC VI LLC and shares voting and investment power of the shares held by OVP VI Entrepreneurs. The Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of his proportionate pecuniary interest therein.
Upon vesting, Reporting Person is entitled to receive one share of common stock for each restricted stock unit.
The restricted stock units vest in three successive and equal annual installments measured from November 30, 2010, such that the restricted stock units will vest in full on the third anniversary of November 30, 2010, subject to the Reporting Person's continued employment or service relationship with the Issuer on each of the vesting dates. Such restricted stock units include a change of control provision such that all unvested awards will immediately vest and become exercisable in connection with a change of control of Issuer.